VANCOUVER, BC / ACCESS Newswire / December 2, 2025 / StimCell Energetics Inc. (OTCQB:STME) ("StimCell" or the "Company"), a biotech…
The multi-year partnership launches with focus on epilepsy, rare disease and AISAN FRANCISCO and ATLANTA, Dec. 02, 2025 (GLOBE NEWSWIRE)…
Veteran gastroenterologist and clinical development leader with deep expertise driving global Phase 2/3 programs across immunology, neurology, and gastrointestinal disease…
Transaction boosts Solta Medical's position to meet rising demand in China's growing aesthetics market LAVAL, QC / ACCESS Newswire /…
Nipocalimab is the first FcRn blocker approved in both adult and adolescent gMG patients aged 12 and older who are…
New analyses from the ongoing open label extension (OLE) studies and findings from electroencephalogram (EEG) assessments in patients with Dravet…
The company will showcase a wave of transformative innovations designed to address the most pressing challenges in healthcare, spanning the…
SIGNA Bolt1, a new 3T MRI scanner, is designed with a next-gen gradient system engineered to support precision diagnostics, clinical…
If approved, lecanemab would be the first and only anti-amyloid treatment in Japan to offer an at-home injection from the…
One Oral Late Breaking Communication and Two Poster PresentationsNEW YORK, Nov. 26, 2025 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp.…